Downloads
-
Inside The Development Of An AAV8 Production Platform
4/24/2025
Explore innovative solutions for AAV8 production challenges, which include scalability and purity, as well as learn how a collaboration with CDMO Matica Biotechnology ensures efficient, high-yield gene therapy vector production.
-
Characterizing Binding Interactions By ITC
4/24/2025
Isothermal Titration Calorimetry is a powerful technique for analyzing biochemical binding events, which is crucial for understanding molecular interactions and enzyme kinetics in biomedical research.
-
FDA RIFs Might Delay Your Review — Here Are Tips For Mitigating
4/24/2025
Mounting concerns that FDA reviewers could start missing PDUFA deadlines have put many on edge. The moment calls for defensive and offensive strategies.
-
PDG-FDA Town Hall Notes — DSCSA Readiness Is At Hand
4/24/2025
Data quality and exceptions handling were key discussion points during a March PDG-FDA town hall, where stakeholders shared updates on progress and unfinished work.
-
ICH Revises Q1 Guideline, Advancing Stability Testing Standards
4/24/2025
In April 2025, the International Council for Harmonisation (ICH) released draft ICH Q1: Stability Testing of Drug Substances and Drug Products for public consultation. This new draft guideline represents the first major overhaul of global stability testing standards in over two decades.
-
Comprehensive CMC-QC Solutions For Cell Therapy
4/23/2025
Learn about comprehensive solutions for cell therapy quality control, including CAR/TCR detection, residual testing, and potency assays, ensure stability, multi-batch validation, and adherence to strict quality standards.
-
CytoPak Products: Closed Process Solutions For Cell Therapy
4/23/2025
Enhance cell therapy workflows with cutting-edge closed-system solutions that simplify processes and support consistent cell growth from research to commercial production.
-
CAR Expression Detection Using Fluorescent Labeled Proteins, Flow Cytometry
4/23/2025
Learn how site-specific fluorescent labeling addresses key challenges in flow cytometry-based evaluations by enhancing assay sensitivity, reducing variability, and ensuring reliable results.
-
Rapid Discovery And Characterization Of Monoclonal Antibodies Against The SARS-CoV-2 Delta Spike Protein
4/23/2025
Delve into the intricate workflow employed for the discovery and characterization of monoclonal antibodies (mAbs) targeting the Delta spike protein.
-
Leveraging Efficiency From CLD To Clinical Manufacturing Of mAbs
4/23/2025
Discover how our efficient strategies can propel your mAb from discovery to clinical manufacturing in as little as 18 months.